Cargando…

Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles

Some previous reports have already shown the characterizations of immunomagnetic reduction (IMR). The assay technology involves the utilities of biofunctionalized magnetic nanoparticles to label target biomolecules. However, the detection threshold and interference tests for IMR have not been invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Kai-Wen, Yang, Shieh-Yueh, Hong, Yu-Wei, Chieh, Jen-Jie, Yang, Che-Chuan, Horng, Herng-Er, Wu, Chau-Chung, Hong, Chin-Yih, Yang, Hong-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356210/ https://www.ncbi.nlm.nih.gov/pubmed/22619536 http://dx.doi.org/10.2147/IJN.S28245

Ejemplares similares

Characteristics of magnetic labeling on liver tumors with anti-alpha-fetoprotein-mediated Fe(3)O(4) magnetic nanoparticles
por: Huang, Kai-Wen, et al.
Publicado: (2012)

In Vivo Screening of Hepatocellular Carcinoma Using AC Susceptibility of Anti-Alpha Fetoprotein-Activated Magnetic Nanoparticles
por: Chieh, Jen-Jie, et al.
Publicado: (2012)

Use of immunomagnetic reduction for C-reactive protein assay in clinical samples
por: Chang, Chien-Hsi, et al.
Publicado: (2012)

Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles
por: Yang, Shieh-Yueh, et al.
Publicado: (2016)

Anti-CEA-functionalized superparamagnetic iron oxide nanoparticles for examining colorectal tumors in vivo
por: Huang, Kai-Wen, et al.
Publicado: (2013)

A Noninvasive Method to Determine the Fate of Fe(3)O(4) Nanoparticles following Intravenous Injection Using Scanning SQUID Biosusceptometry
por: Tseng, Wei-Kung, et al.
Publicado: (2012)

Characterizations of Anti-Alpha-Fetoprotein-Conjugated Magnetic Nanoparticles Associated with Alpha-Fetoprotein for Biomedical Applications
por: Liao, Shu-Hsien, et al.
Publicado: (2017)

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017)

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
por: Lin, Chin-Hsien, et al.
Publicado: (2018)

Discriminating Hepatocellular Carcinoma in Rats Using a High-T(c) SQUID Detected Nuclear Resonance Spectrometer in a Magnetic Shielding Box
por: Huang, Kai-Wen, et al.
Publicado: (2012)

Correction: Discriminating Hepatocellular Carcinoma in Rats Using a High-T(c) SQUID Detected Nuclear Resonance Spectrometer in a Magnetic Shielding Box
por: Huang, Kai-Wen, et al.
Publicado: (2014)

Magnetic Clustering Effect during the Association of Biofunctionalized Magnetic Nanoparticles with Biomarkers
por: Chen, Kuen-Lin, et al.
Publicado: (2015)

Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease
por: Yang, Shieh-Yueh, et al.
Publicado: (2017)

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
por: Chang, Chun-Wei, et al.
Publicado: (2020)

Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma
por: Wei, Zhewen, et al.
Publicado: (2022)

Development of antibody functionalized magnetic nanoparticles for the immunoassay of carcinoembryonic antigen: a feasibility study for clinical use
por: Yang, Che-Chuan, et al.
Publicado: (2014)

Eight-Channel AC Magnetosusceptometer of Magnetic Nanoparticles for High-Throughput and Ultra-High-Sensitivity Immunoassay
por: Chieh, Jen-Jie, et al.
Publicado: (2018)

Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
por: Yang, Shieh-Yueh, et al.
Publicado: (2017)

Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy
por: Sun, Li-Yue, et al.
Publicado: (2022)

Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection
por: Lin, Kongying, et al.
Publicado: (2021)

Using Bio-Functionalized Magnetic Nanoparticles and Dynamic Nuclear Magnetic Resonance to Characterize the Time-Dependent Spin-Spin Relaxation Time for Sensitive Bio-Detection
por: Liao, Shu-Hsien, et al.
Publicado: (2014)

Alpha-fetoprotein producing renal cell carcinoma: a case report.
por: Hong, S. M., et al.
Publicado: (1998)

Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report
por: Lin, Hung-Hsin, et al.
Publicado: (2016)

Novel characteristics of alpha-fetoprotein (AFP)-producing gastric cancer
por: Sun, Wenhui, et al.
Publicado: (2017)

Human Alpha Fetoprotein in Body Fluids
por: Smith, J. A., et al.
Publicado: (1971)

Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
por: Wang, Xiaoping, et al.
Publicado: (2018)

Racial disparities in alpha‐fetoprotein testing and alpha‐fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients
por: Wu, Guoyi, et al.
Publicado: (2019)

Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
por: Lee, Chao-Wei, et al.
Publicado: (2019)

Multiplex Immunoassays Utilizing Differential Affinity Using Aptamers Generated by MARAS
por: Lai, Ji-Ching, et al.
Publicado: (2017)

Clinicopathologic and prognostic characteristics of alpha-fetoprotein–producing gastric cancer
por: He, Ruji, et al.
Publicado: (2017)

Cellular and genetic restrictions in the immunoregulatory activity of alpha-fetoprotein. II. Alpha-fetoprotein-induced suppression of cytotoxic T lymphocyte development
Publicado: (1978)

Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer
por: Wang, Ruhan, et al.
Publicado: (2020)

Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma
por: Lee, Jin-Chiao, et al.
Publicado: (2019)

Genetic control of alpha-fetoprotein synthesis in the mouse
Publicado: (1977)

Hepatoid adenocarcinoma of the gallbladder with production of alpha-fetoprotein
por: Lee, Jae Hoon, et al.
Publicado: (2011)

Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response
Publicado: (1975)

In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles
por: Hsieh, Wan-Ju, et al.
Publicado: (2012)

Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients
por: Yen, Yi-Hao, et al.
Publicado: (2023)

Hepatoid Adenocarcinoma of Stomach: Emphasis on the Clinical Relationship with Alpha-Fetoprotein-Positive Gastric Cancer
por: Chen, Er-Bao, et al.
Publicado: (2019)

Photoelectrochemical detection of alpha-fetoprotein based on ZnO inverse opals structure electrodes modified by Ag(2)S nanoparticles
por: Jiang, Yandong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3eq2fha20dotujtsm62rldlq6p